I do the “ETF of the Week” for MarketWatch every week on Chuck Jaffe’s MoneyLife Show where I highlight big movers and disappointments among exchange traded funds.
On Thursday, I highlighted the SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH). The pharma sector will maintain momentum ahead on strong merger and acquisition activity.
Click here to listen to the podcast.
To access previous podcasts, take a look at our podcasts category.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.